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Monolayers of MC3T3-E1 were cultured for 21D in aMEM + 10%FBS,
supplemented with BGP and AA. mRNA expression of typical chon-
drogenesis markers (Aggrecan (Agg), type II (Col2a1) and X (Col10a1))
collagens and osteogenic markers (Osterix (Osx), Osteocalcin (Ocn) and
Osteopontin (Opn)) were assessed by quantitative RT-PCR. We also
assessed mRNA expression of Wnts (-4, -5a, -5b, -11) and BMPs (-2, -4,
-6, -7). Quantiﬁcation of Alcian Blue, Safranin O, Sirius red and Alizarin
red staining were used to evaluate proteoglycans, collagens and
mineralized content respectively. Alkaline phosphatase (ALP) activity
allowed to monitor osteogenesis. SDS-PAGE was used to assess the
global glycosylation status. Western blot allowed to check canonical (b-
catenin) and non-canonical (Calmodulin-Kinase II) Wnt signaling, as
well as BMP signaling (Smad and MAPK).
Results: During early proliferation (D1-7) and late proliferation/pre-
hypertrophy phases (D7-14) of chondrogenesis, Col2a1 and Agg mRNA
strongly increased, but to a lesser extent in COG5-. Proteoglycan
staining intensity was lower in COG5-. BMP-4 levels progressively
increased and were signiﬁcantly higher in COG5-. This was consistent
with increased phosphorylation of Smad 1/5/8. Wnt-4, -5a and -5b
mRNA were evenly increased in both controls and COG5-. BMP-6 and
Col10a1 mRNA were increased at D14, but were signiﬁcantly lower in
COG5-. Wnt-11 mRNA increased in controls, but not in COG5-. In
mineralization phase (D14 to D21), Col10a1 mRNA and mineralization
were strongly increased, but to a lesser extent in COG5-. During
osteogenesis, Opn, Osx and Ocn mRNA were signiﬁcantly higher in
controls, alike Alizarin red staining and ALP activity. Protein analysis
suggested differences in global glycosylation status, in particular of Wnt
ligands.
Conclusions: COG5 defect reduces chondrogenesis and osteogenesis.
COG5 particularly affected glycosylation andWnt signaling, underlining
its critical role in the fate of cells from the articular chondrocyte-bone
unit in the course of OA.232
ROLE OF INTERLEUKIN-10 IN ENDOCHONDRAL BONE FORMATION
G. Kim y,z, Y.-K. Jung z, H.-R. Park z, E.-J. Lee z, J.-Y. Choi x, F. Beier {,k,
S.-W. Han y,z. yDept. of Rheumatology, Daegu Fatima Hosp., Daegu,
Republic of Korea; z Lab. for Arthritis and Bone Biology, Fatima Research
Inst., Daegu, Republic of Korea; xDept.s of Biochemistry and Cell Biology,
Sch. of Med., WCU program, Kyungpook Natl. Univ., Daegu, Republic of
Korea; kDept. of Physiology and Pharmacology, Univ. of Western
Ontario, London, ON, Canada; {Children's Hlth.Res. Inst., London, ON,
Canada
Purpose: Interleukin-10 (IL-10) is a pleiotrophic immunoregulatory
cytokine that has been shown to be elevated in cartilage and synovium
of osteoarthritis and has a chondroprotective effect. However, the role
of IL-10 during endochondral bone formation has not been well eluci-
dated. We intended to investigate the effect of IL-10 on endochondral
bone formation.
Methods: Loss- and gain of IL-10 function in endochondral bone
formation was studied with IL-10 null mice and IL-10-treated E15.5
tibia organ cultures, respectively. Primary chondrocytes from long
bones of E15.5 mice were cultured with or without IL-10 (10 ng/ml),
and the effects of IL-10 on chondrocyte marker genes or proteins were
assessed by real-time polymerase chain reaction and Western blot
analysis. Proliferation of primary chondrocytes was determined by
MTT assay.
Results:Whole skeletal stain of IL-10 null mice did not show signiﬁcant
difference in gross development compared with WT littermates, except
reduced occipital bone formation. Treatment with IL-10 signiﬁcantly
increased the length of tibiae in organ culture. IL-10 caused an increase
of both proliferating and hypertrophic zone length compared to control
group, but the proportion of either zone relative to total growth plate
length was not different between IL-10-treated and control groups. IL-
10 induces chondrogenic and hypertrophic differentiation as well as
proliferation of chondrocytes in vitro. Real-time PCR data revealed that
IL-10 treatment resulted in slight but signiﬁcant increases in the mRNA
expression of both chondrogenic and hypertrophic marker genes,
including aggrecan, type 2 collagen, type 10 collagen, osteopontin, and
MMP-13. Also, IL-10 increased the expression of Sox9 and Runx2 at m-
RNA and protein level. MTT assay showed that IL-10 signiﬁcantly
increased a proliferation of chondrocytes.Conclusions: These data represent the ﬁrst evidence that IL-10 induces
the chondrogenesis, chondrocyte proliferation and hypertrophic
differentiation through Sox9 and Runx2.233
DYSREGULATED FOXO TRANSCRIPTION FACTORS IN ARTICULAR
CARTILAGE IN AGING AND OSTEOARTHRITIS
Y. Akasaki y, R. Liu-Bryan z, R. Terkeltaub z, M. Lotz y. y The Scripps Res.
Inst., La Jolla, CA, USA; zUniv. of California San Diego, La Jolla, CA, USA
Background/Purpose: Aging-associated changes in articular chon-
drocytes represent a major risk factor for cartilage degradation and
osteoarthritis (OA). The major signaling pathway that regulates cellular
aging and stress resistance is the Insulin/IGF-1 signaling pathway. In
this pathway, Forkhead-box class O (FoxO) transcription factors play
central roles in protein quality control, autophagy and cellular defenses
against oxidative stress. The objective of this study was to analyze
expression and activation of FoxO transcription factors in normal, aging
and OA cartilage.
Methods: Human knee joints from individuals ages 23-90 were ob-
tained at autopsy. The entire femoral condyles of knee joints were
harvested from 6 young normal donors (mean  SD ¼ 36.0  9.6 years
old, OA grade I). Aged knee joints were also obtained from 4 donors
(mean  SD ¼ 72.5  3.6 years) with no history of arthritis and normal
or minimally ﬁbrillated cartilage (OA grade I-II). OA human joints were
obtained from 4 donors (mean  SD ¼ 81.5  10.3 years, OA grade III-
IV). Knee joints were also obtained frommice at the age of 4, 12, and 24
months and following surgically induced OA. Expression of FoxO
proteins was analyzed by immunohistochemistry and western blotting.
Regulation of FoxO protein expression and activation was analyzed in
cultured chondrocytes stimulated with cytokines, growth factors and
oxidants.
Results: Human cartilage expressed predominantly FoxO1 and FoxO3
but not FoxO4 protein as detected by western blotting. Immunohis-
tochemistry showed that normal human articular cartilage expressed
FoxO1 and FoxO3 proteins more strongly in chondrocytes in the
superﬁcial and mid zone as compared to the deep zone. FoxO showed
mainly nuclear localization in young normal cartilage. Areas of
cartilage exposed to minimal versus maximal weightbearing showed
no signiﬁcant difference in young normal cartilage except for the
deep zone where FoxO3 was more strongly expressed. During human
joint aging, expression of FoxO1 and FoxO3 was markedly reduced in
the superﬁcial zone of cartilage regions exposed to maximal
weightbearing. In OA-affected cartilage, chondrocyte clusters showed
strong FoxO phosphorylation and cytoplasmic localization. Similar
patterns of FoxO expression in normal joints and changes in aging
and OA joints were observed in mouse models. In cultured chon-
drocytes, the longer-term (2-5 day) treatment with proinﬂammatory
cytokines IL-1b and TNF-a suppressed FoxO1 protein, while TGF-
b and PDGF increased FoxO1 and FoxO3 expression, respectively.
FoxO1 and FoxO3 phosphorylation was increased signiﬁcantly by
short-term (60 minutes) exposure to IL-1b, PDGF, b-FGF, IGF-1, and
the oxidant t-BHP.
Conclusions: Normal articular cartilage has a tissue speciﬁc signature of
FoxOs expression and activation. Aging and OA in humans and mice is
associated with profound changes in FoxO expression and activation.
These results suggest that changes in FoxO expression and activation
may be involved in cartilage aging and OA, and provide a foundation
upon which the function of FoxOs in cartilage homeostasis, aging and
OA can be examined.234
NEUROPEPTIDE REGULATION OF CHONDROCYTE GENE EXPRESSION
D. Bevan y, M.B. Goldring z, I. Clark y, S. Donell x, J. Gavrilovic y. yUniv. of
East Anglia, Norwich, Norwich, United Kingdom; zWeill Cornell Med.
Coll., NY, USA; xNorfolk and Nowich Univ. Hosp., Norwich, United Kingdom
Purpose: Damaged cartilage is increasingly recognised as a permissive
environment for neurovascular inﬁltration. Neuropeptides involved in
pain transmission in osteoarthritis, have recently been implicated in
cartilage breakdown and also in chondrocyte proliferation and
survival. We took an unbiased approach to explore the effect of
substance P and bradykinin on expression 95 genes which may be
important in cartilage breakdown including all members of the MMP,
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TIMPs, all CCN growth factor family members, certain FGFs and
neuropeptide precursors and receptors in immortalised human chon-
drocytes, C28/I2.
Methods: We compared the response of C28/I2 cells cultured in
monolayer (2D) or on polyhema (3D; preventing cell adhesion to the
culture plastic) which is known to maintain chondrocyte phenotype,
exploring expression of 95 genes analysed by Taqman Low Density
Array. Ten genes showed signiﬁcant changes (p< 0.05) of at least 2-fold.
Results: In 2D cultures Interleukin 6 (IL6) was up-regulated 3-fold by
both bradykinin and Substance P. IL6 is up-regulated in OA joint ﬂuid
and elevated IL6 is associated with enhanced sensitivity to pain.
Although in 3D culture no signiﬁcant modulation of IL6 was observed
by neuropeptides we did observe up-regulation of IL6 expression in
response to IL1/Oncostatin M (used as a positive control). In 3D culture
expression of six genes was signiﬁcantly repressed (at least 2-fold) by
both bradykinin and substance P and no genes were signiﬁcantly
induced. Amongst these genes it was interesting to note suppression of
inhibitors TIMP2 (inhibitor of all MMPs) and TIMP3 (inhibits all MMPs,
certain ADAMs and ADAMTS proteinases). Expression of three metal-
loproteinases, ADAMTS9 (an aggrecanase), MMP2 and MMP15 was also
signiﬁcantly suppressed although expression of these enzymes was still
high. FGF18 was also suppressed by both neuropeptides in 3D only and
this growth factor has been shown to promote cartilage repair. WISP3/
CCN6 was repressed 2-fold in 3D culture by both neuropeptides. We
have previously demonstrated that WISP3/CCN6 is up-regulated in end
stage OA cartilage and regulates MMP and ADAMTS4 and 5 in chon-
drocytes. Whilst neurotrophin BDNF expression was repressed by both
neuropeptides, tachykinin 3 (the precursor to neurokinin B) was also
repressed fold by bradykinin but interestingly not by the tachykinin
substance P. We also explored expression of two of the genes regulated
in C28/I2 cells by qPCR analysis in primary human chondrocytes and
conﬁrmed that expression of both WISP3/CCN6 and TIMP3 was also
repressed by the two neuropeptides.
Conclusions: Overall our data suggest that the effects of substance P
and bradykinin on chondrocyte gene expression and matrix metabo-
lism are environment-dependent.235
LOCAL RAS IN THE HYPERTROPHIC DIFFERENTIATION OF
CHONDROCYTES
I. Tsukamoto y, M. Akagi y, S. Inoue y, Y. Oda y, T. Teramura z,
T. Takehara z, Y. Onodera z. yDept. of Orthopaedic Surgery, Faculty of
Med., Kinki Univ., Osaka-Sayama City, Japan; zDiv. of Cell Biology for
Regenerative Med., Kinki Univ., Osaka-Sayama City, Japan
Purpose: Recently, the local renin-angiotensin system (RAS) has
attracted many researchers in many pathophysiological issues. Also in
orthopedics, expression of the local RAS was found in fracture callus,
bone tissues and arthritic synovium. In the last year, we reported that
the local RAS expressed in chondrocytes of the epiphyseal plates of
mice. The purpose of this study is to reveal immunohistological local-
ization of the RAS components in the limb buds of mice where another
physiological hypertrophic differetiation occurs and to analyze function
of the local RAS in the processes of hypertrophic differentiation using
ATDC5 cell line.
Methods: The limb buds of 15-day-viviparous mice were immuno-
stained with antibodies to angiotensinogen, angiotensinogen convert-
ing enzyme 1 (ACE1), angiotensinII type 1 receptor (AT1R) and
angiotensinII type 2 receptor (AT2R). We cultured ATDC5 cell line and
evaluated expression of angiotensinogen, ACE1, AT1R and AT2R during
the hypertrophic term using quantitative real-time PCR and Western
blot analysis. Then, we separately stimulated AT1R and AT2R in
hypertrophic term using angiotensin II, olmesartan and PD123319 and
evaluated expression of type X collagen using quantitative real-time
PCR and Western blot analysis.
Results: In the limb buds of mice, angiotensinogen and AT1R
expressed in the resting chondrocytes, the proliferative chondrocytes
and hypertrophic chondrocytes; however, ACE1 and AT2R expressed
only in the hypertrophic chondrocytes. In ATDC5 cell line, angio-
tensinogen and AT1R expressed mainly in the proliferative term and
slightly in the hypertrophic term; conversely, ACE1 and AT2R
expressed mainly in the hypertrophic term and slightly in the prolif-
erating term. In the hypertrophic term, expression of type X collagenwere downregulated activating AT1R and were conversely upregu-
lated activating AT2R.
Conclusions: The local RAS also expresses in the limb buds of mice. In
the hypertrophic term of the chondrocyte differentiation, activating
AT1R decelerates the hypertrophic differentiation; conversely, acti-
vating AT2R accelerates the hypertrophic differentiation. Therefore,
the local RAS might regulate the chondrocyte hypertrophic differen-
tiation.236
PRONOUNCED DECREASE IN EXPRESSION OF CHONDROPROTECTIVE
SMAD2/3 PHOSPHORYLATING TGFb-SIGNALING RECEPTORS DURING
AGEING IN HEALTHY CARTILAGE
A. van Caam, E. Blaney Davidson, W. Madej, W. van den Berg, P. van der
Kraan. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, The Netherlands
Purpose: Osteoarthritis (OA) is a multi-factorial disease involving bone,
synovium and cartilage, with ageing as its key risk factor. Signaling by
the Transforming Growth Factor b (TGFb)-superfamily of ligands via
Smad phosphorylation (SmadP) plays a crucial role in cartilage
homeostasis, as Smad1/5/8p induces while Smad2/3p protects against
chondrocyte hypertrophy. In cartilage, age-related changes in expres-
sion of TGFb-superfamily members, like TGFb1 and BMP7, have been
observed. Furthermore, age-related changes in expression of the TGFb-
superfamily receptors ACVRL1 (ALK1) and TGFBRI (ALK5) are thought to
be involved in onset of OA. Based on these ﬁndings, we wanted to
investigate if gene expression of other members of the TGFb-super-
family signaling pathway changes during ageing in healthy cartilage.
Therefore, in this study we set out to identify age-related changes in
expression of TGFb-superfamily members and their receptors in normal
cartilage.
Methods: From the metacarpophalangeal joint of freshly butchered (<
3 h post mortem), cows (Bos Taurus) (n¼ 32, 7 male, 25 female), 28 mm2
full thickness cartilage explants were collected with a biopsy punch.
Age of the animals ranged from 1 up to 10 years, and samples were
evenly spread over this range. Macroscopically, none of the animals
showed any signs of OA. Samples were taken from the apical side of the
metacarpal chondyle medial to the intertrochlear notch, quickly
washed in saline to remove synovial ﬂuid, and ﬂash frozen in liquid
nitrogen. Cartilage was pulverized using a dismembrator and RNA was
extracted using the RNAeasy method. Gene expression was measured
by quantitative real time PCR, using cDNA speciﬁc primers and SYBR-
green. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used
as internal control. Regression analyses were done using SPSS.
Results: To assess the validity of the dataset, Collagen type 2 alpha 1
(Col2A1), and Tgfb1 , expression was measured, as expression of both
genes should decrease during ageing. Col2A1 expression decreased
4000-fold (R2 ¼ 0.85, p < 0.0001) fold, and Tgfb1 over 2 fold (R2 ¼ 0.35,
p¼ 0.0007) in a linear fashion between young and old animals, showing
that our dataset is valid for studying ageing of healthy cartilage .
Subsequently expression of TGFb-superfamily type I and type II recep-
tors was measured. Most notably, expression of all three Smad2/3
phosphorylating receptors, Acvr1b (ALK4) (R2 ¼ 0.36, p ¼ 0.0043),
Tgfbr1 (ALK5) (R2 ¼ 0.21, p ¼ 0.0077), and Acvr1c (ALK7) (R2 ¼ 0.26, p ¼
0.0317), was lowered by, on average, 4-fold during ageing, while of the
four Smad1/5/8 phosphorylating receptors only expression of Bmpr1a
(ALK3) (R2 ¼ 0.19, p ¼ 0.012) was lowered by 2-fold. Of the type II
receptors, only a decrease of approximately 3-fold in Bmpr2 (R2 ¼ 0.42,
p ¼ 0.0002) expression could be observed. No change in expression of
the two type III receptors Eng and Tgfbr3 was found. Furthermore no
changes in expression of the following members of the Transforming
Growth Factor b (TGFb)-superfamily: Tgfb2, Tgfb3, Bmp2, Bmp4, Gdf5 and
Bmp7 were observed.
Conclusions: Age-related changes previously observed in human and
murine cartilage could also be observed in bovine cartilage, showing the
validity of our dataset. We observed more changes in receptor expres-
sion than in growth factor (ligand) expression, suggesting a more
important role for change in receptor expression during the ageing
process compared to change in ligand expression. Strikingly, in our
dataset, expression of all three Smad2/3p phosphorylating receptors
was lowered during ageing, while expression of Smad1/5/8 phosphor-
ylating receptors remained largely unaffected. Given the importance of
Smad2/3p in maintaining articular cartilage phenotype, this can
underlie the increased responsiveness of aged chondrocytes to
processes that induce terminal differentiation.
